Home | Terms of Use | Privacy Statement | Contact Us For U.S. healthcare professionals only.
		About Oral Mucositis   Video Watch a Biological  Video online...   Impact, Prevalence & Management Information about incidence, effects on patients, and ways to help manage severe oral mucositis. Pathophysiology Important facts about various phases of oral mucositis. Etiology Specific information about each stage of oral mucositis. Assessment Ways to measure the impact of oral mucositis. ABOUT ORAL MUCOSITIS ABOUT KEPIVANCE® TOOLS AND RESOURCES FOR NURSES FOR PHARMACISTS IMPORTANT PRODUCT SAFETY INFORMATION
	Kepivance® is indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy requiring hematopoietic stem cell support. The safety and efficacy of Kepivance® have not been established in patients with non-hematologic malignancies. Important Safety Information In patients with hematologic malignancies, the most common serious adverse reaction in clinical trials attributed to Kepivance® was skin rash reported in less than 1% of patients.   Contact | Reimbursement | Biovitrum.com | Site Map Prescribing Information © 2008 Biovitrum AB (publ). All rights reserved.